Why This Billion-Dollar Startup Entrepreneur Treats Investors Like Collaborators Lyra Health is expected to hit more than $100 million in revenue by the end of the year, and the latest funding round brings its valuation to $1.1B. Cofounder and CEO David Ebersman discusses his best practices when it comes to investor relationships